Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology
Disease Category: Vaccines
Trial Information
Clinical trial to test a study drug Staphylococcus aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery.
The purpose of this experimental study is to: Test the ability of V710 to prevent serious S. aureus infections in the bloodstream or in the chest wound after your open-heart surgery, before your open-heart surgery and to test the ability of V710 to cause an immune response (the ability of the body to fight infection after vaccination).
Study drug and study procedures will be made available to you at no cost.
To qualify, you must:
- Be at least 18 years old
- Scheduled to undergo cardiothoracic surgery
You will not qualify if you:
- Are pregnant or breast-feeding
- Have received a live virus vaccine within 30 days prior to receipt of the study vaccine or is scheduled to receive any live virus vaccine within 30 days post vaccination
- Have participated in another clinical trial in the 4 weeks prior to study entry, or plans to participate in a treatment-based trial or another trial in which an invasive procedure is to be performed, at any time through postoperative Day 90.
Arlene Travis, Research Coordinator
Biomedical Research Alliance of New York
Mount Sinai School of Medical Center
Box 1030
One Gustave L. Levy Place
New York, NY 10029
Phone: 212-241-8544
EMail: Arlene.travis@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
